title: Biclonal follicular lymphoma: histological, clinical and molecular characteristics.
authors.forename: María Fernanda
authors.initials: MF
authors.lastname: Noriega
authors.forename: Carlos
authors.initials: C
authors.lastname: De Brasi
authors.forename: Marina
authors.initials: M
authors.lastname: Narbaitz
authors.forename: Andrea
authors.initials: A
authors.lastname: Rodríguez
authors.forename: Irma
authors.initials: I
authors.lastname: Slavutsky
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001483:Base Sequence; D056905:Chromosome Breakpoints; D002999:Clone Cells; D003907:Dexamethasone / Q000008:administration & dosage; D005260:Female; D015321:Gene Rearrangement; D019254:Genes, bcl-2; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology*; D008942:Mitoxantrone / Q000008:administration & dosage; D008969:Molecular Sequence Data; D009367:Neoplasm Staging; D016133:Polymerase Chain Reaction; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D003907:Dexamethasone; D008942:Mitoxantrone; D014740:Vidarabine; C024352:fludarabine